The Biotech Pulse S1E4 - the role of biotech as the ‘discovery engine’ for pharma

This episode showcases the role of biotech as the ‘discovery engine’ for pharma in high-risk areas of R&D. It features General Partner Dmitrij (Dima) Hristodorov as he interviews Felix Lansing, co-founder and CTO of Seamless Therapeutics, together with Albert Seymour, CEO of Seamless Therapeutics, on using recombinases to make gene editing more targeted and efficient. See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Jun 12, 2024

Embed this episode

Attribution link and audio player

Ready to play

The Biotech Pulse S1E4 - the role of biotech as the ‘discovery engine’ for pharma

0:00 24:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Biotech Pulse?

This episode is 24 minutes long.

When was this The Biotech Pulse episode published?

This episode was published on June 12, 2024.

Can I download this The Biotech Pulse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!